Stockholm - Free Realtime Quote SEK

Fluicell AB (publ) (FLUI.ST)

10.80
-0.90
(-7.69%)
As of 11:06:57 AM GMT+2. Market Open.
Currency in SEK All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,770
1,859
3,338
3,251
2,602
Cost of Revenue
-4,036
-1,901
1,600
663
715
Gross Profit
5,806
3,760
1,738
2,588
1,887
Operating Expense
16,438
19,602
28,617
24,314
23,582
Operating Income
-10,632
-15,842
-26,879
-21,726
-21,695
Net Non Operating Interest Income Expense
386
427
849
311
2
Pretax Income
-10,344
-15,511
-26,554
-21,606
-21,693
Tax Provision
--
--
0
0
--
Net Income Common Stockholders
-10,344
-15,511
-26,554
-21,606
-21,693
Diluted NI Available to Com Stockholders
-10,344
-15,511
-26,554
-21,606
-21,693
Basic EPS
-13.22
-11.29
-79.41
-71.80
-131.80
Diluted EPS
-13.22
-11.29
-79.41
-71.80
-131.80
Basic Average Shares
1,373.70
1,373.70
334.41
300.92
164.59
Diluted Average Shares
1,373.70
1,373.70
334.41
300.92
164.59
Total Operating Income as Reported
-10,634
-15,842
-26,879
-21,726
-21,695
Total Expenses
12,402
17,701
30,217
24,977
24,297
Net Income from Continuing & Discontinued Operation
-10,344
-15,511
-26,554
-21,606
-21,693
Normalized Income
-10,344
-15,511
-26,554
-21,606
-21,693
Interest Income
--
506
879
358
29
Interest Expense
80
79
30
47
27
Net Interest Income
386
427
849
311
2
EBIT
-10,264
-15,432
-26,524
-21,559
-21,666
EBITDA
-9,842
-14,992
-25,914
-20,839
-21,078
Reconciled Cost of Revenue
-4,036
-1,901
1,600
663
715
Reconciled Depreciation
422
440
610
720
588
Net Income from Continuing Operation Net Minority Interest
-10,344
-15,511
-26,554
-21,606
-21,693
Normalized EBITDA
-9,842
-14,992
-25,914
-20,839
-21,078
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/18/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BT3.BE Lineage Cell Therapeutics Inc
0.5850
-0.85%
 
GXE.F Galapagos NV
24.40
-1.37%
 
ITRX inTerra Resources Corp
0.0240
0.00%
 
GENSY Genus plc
24.34
0.00%
 
8QQ.BE AbCellera Biologics Inc
2.5800
-6.99%
 
300759.SZ Pharmaron Beijing Co., Ltd.
24.84
-2.47%
 
AB3A.MU Sarepta Therapeutics Inc
31.60
-1.86%
 
AYJ.HA Valneva SE
2.6880
-1.54%
 
ONCIN.OL Oncoinvent ASA
2.0250
0.00%
 
ERGO Entia Biosciences, Inc.
0.0001
0.00%